Fundus autofluorescence lifetimes in age‐related macular degeneration versus healthy controls in a pseudophakic population
Acta Ophthalmologica · 2025
DOI: 10.1111/aos.17519 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Ophthalmologica, 2025. Verfasst von Jana Oertel und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University Hospital Jena, Jena, Germany. Hauptthemen laut MEDLINE: Pseudophakia, Fluorescein Angiography, Ophthalmoscopy, Macular Degeneration. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Purpose
To check whether prolonged fundus autofluorescence (FAF) lifetimes in age‐related macular degeneration (AMD) could be an artefact resulting from lens fluorescence.
Methods
Fluorescence lifetime imaging ophthalmoscopy (FLIO) was performed in pseudophakic intermediate AMD as well as healthy controls. The median values of FAF lifetimes in the centre, the inner and the outer ring of the ETDRS grid, obtained as amplitude‐weighted mean of the lifetimes from a three‐exponential fit of the fluorescence decay over time in two spectral channels, as well as peak emission wavelengths (PEW) were compared between patients and controls. The age dependence of FAF lifetime was checked per group. In the patient cohort, FAF lifetimes of individuals with and without subretinal drusenoid deposits (SDD) were compared.
Results
Forty‐four AMD patients (mean age 80.0 ± 6.0 years) and 26 controls (mean age 73.0 ± 10.2 years) were included. The FAF lifetimes of a subgroup of patients ( N = 25, mean age 76.3 ± 5.6 years), age‐matched to the controls, were significantly longer than those of the controls (all grid areas and spectral channels p < 0.001). FAF lifetimes increased with age in the controls ( p = 0.006–0.03), but not in the patients. Patients with SDD had longer FAF lifetimes than those without ( p = 0.003–0.068). PEW neither showed significant group differences nor age dependence.
Conclusions
Although long fluorescence lifetimes of the lens can affect FAF lifetime measurements, prolonged FAF lifetimes in AMD are specific to the disease and not a lens artefact as shown in pseudophakic eyes. The effect of AMD on the lifetimes outweighs that of age. Patients with SDD, who have a higher risk of AMD progression, also show longer FAF lifetimes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, University Hospital Jena, Jena, Germany.
- Center for Medical Optics and Photonics, University of Jena, Jena, Germany.
ORCID-Profile: Martin Hammer
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Oertel, J., Fischer, D., Tarhan, M., Meller, D., & Hammer, M. (2025). Fundus autofluorescence lifetimes in age‐related macular degeneration versus healthy controls in a pseudophakic population. Acta Ophthalmologica. https://doi.org/10.1111/aos.17519
Vancouver
Oertel J, Fischer D, Tarhan M, Meller D, Hammer M. Fundus autofluorescence lifetimes in age‐related macular degeneration versus healthy controls in a pseudophakic population. Acta Ophthalmologica. 2025. doi:10.1111/aos.17519
BibTeX
@article{Oertel2025,
author = {Oertel, Jana and Fischer, Dominik and Tarhan, Melih and Meller, Daniel and Hammer, Martin},
title = {Fundus autofluorescence lifetimes in age‐related macular degeneration versus healthy controls in a pseudophakic population},
journal = {Acta Ophthalmologica},
year = {2025},
doi = {10.1111/aos.17519}
}
EUVIMED